This inventor holds 4 USPTO granted patents and 4 published patent applications. Top assignees: Versitech, Inc., Emv Enhance (Hk) Limited. Active years: 2020-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
4 out of 144 
1 out of 1 Years Active: 2020-2024
Title: Innovations and Contributions of Inventor Kai Wang Kelvin To
Introduction
Kai Wang Kelvin To is a notable inventor based in Hong Kong, CN. He has made significant contributions to the field of immunology and vaccine development. With a total of 4 patents, his work focuses on enhancing immune responses and improving vaccine production.
Latest Patents
One of his latest patents involves compositions and methods for enhancing immune response to vaccination and improving vaccine production. This patent utilizes Miltefosine to enhance immune response, particularly for influenza and coronavirus vaccinations. Additionally, it provides methods for enhancing viral yield in cultured cells through the application of a cannabinoid receptor agonist, such as methanandamide. This enhanced viral yield can be crucial for vaccine formulation and improving sensitivity in cell-based virus assays. Another significant patent by To describes compositions and methods for providing a prognosis for influenza infection. This innovation allows for prognostic determination of the severity of influenza infection based on the PDE3A status of an individual. Impaired PDE3A function is linked to severe symptoms when contracting influenza, and specific SNP mutations associated with this impairment are identified, along with primers and kits for their detection.
Career Highlights
Throughout his career, Kai Wang Kelvin To has worked with various companies, including Versitech, Inc. and Emv Enhance (HK) Limited. His experience in these organizations has contributed to his expertise in the field of immunology and vaccine research.
Collaborations
He has collaborated with notable individuals in his field, including Johnson Yiu-Nam Lau and Kwok Yung Yuen. These collaborations have further enriched his research and innovations.
Conclusion
Kai Wang Kelvin To's contributions to vaccine development and immunology are noteworthy. His innovative patents and collaborations reflect his commitment to enhancing public health through scientific advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile